Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5415 | 1626 | 39.5 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
109 | 2 | CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA | 25223 |
5415 | 1 | MANTLE CELL LYMPHOMA//T1114//SOX11 | 1626 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MANTLE CELL LYMPHOMA | authKW | 8655287 | 42% | 67% | 683 |
2 | T1114 | authKW | 578642 | 3% | 72% | 43 |
3 | SOX11 | authKW | 385921 | 2% | 53% | 39 |
4 | BCL 1 | authKW | 324974 | 2% | 58% | 30 |
5 | MULTIPLE LYMPHOMATOUS POLYPOSIS | authKW | 208994 | 1% | 70% | 16 |
6 | MANTLE CELL | authKW | 193661 | 1% | 54% | 19 |
7 | BLASTOID VARIANT | authKW | 189340 | 1% | 92% | 11 |
8 | CENTROCYTIC LYMPHOMA | authKW | 186667 | 1% | 76% | 13 |
9 | T1114Q13Q32 | authKW | 176030 | 1% | 63% | 15 |
10 | CYCLIN D1 | authKW | 145306 | 8% | 6% | 136 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 27346 | 40% | 0% | 643 |
2 | Oncology | 11448 | 44% | 0% | 710 |
3 | Pathology | 9347 | 22% | 0% | 353 |
4 | Medical Laboratory Technology | 607 | 3% | 0% | 56 |
5 | Transplantation | 85 | 2% | 0% | 31 |
6 | Genetics & Heredity | 47 | 4% | 0% | 61 |
7 | Gastroenterology & Hepatology | 43 | 2% | 0% | 39 |
8 | Anatomy & Morphology | 33 | 1% | 0% | 13 |
9 | Cell Biology | 32 | 4% | 0% | 73 |
10 | Medicine, Research & Experimental | 27 | 3% | 0% | 45 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOMA MYELOMA | 93986 | 4% | 8% | 63 |
2 | HEMATOPATHOL SECT | 71691 | 2% | 10% | 39 |
3 | HEMATOPATHOL | 61571 | 5% | 4% | 89 |
4 | CCG LEUKEMIA | 50071 | 0% | 67% | 4 |
5 | HEMATOPATHOL UNIT | 45713 | 1% | 14% | 18 |
6 | JOHN THEURER CANC | 42870 | 1% | 12% | 19 |
7 | HAEMOLYMPHOPATHOL UNIT | 37555 | 0% | 100% | 2 |
8 | HOSP CLIN BARCELONA PATHOL ANAT | 37555 | 0% | 100% | 2 |
9 | SEZ STUDI BIOCHIM PATOL GENOMA UMANO | 37555 | 0% | 100% | 2 |
10 | LYMPH NODE REGISTRY | 34054 | 1% | 13% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA & LYMPHOMA | 32649 | 7% | 2% | 115 |
2 | BRITISH JOURNAL OF HAEMATOLOGY | 10461 | 5% | 1% | 87 |
3 | AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 8469 | 4% | 1% | 62 |
4 | BLOOD | 8424 | 8% | 0% | 125 |
5 | ANNALS OF ONCOLOGY | 6589 | 3% | 1% | 54 |
6 | MODERN PATHOLOGY | 5615 | 2% | 1% | 38 |
7 | LEUKEMIA | 4975 | 3% | 1% | 45 |
8 | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 4262 | 1% | 1% | 20 |
9 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 4145 | 1% | 2% | 13 |
10 | HEMATOLOGICAL ONCOLOGY | 3690 | 1% | 2% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MANTLE CELL LYMPHOMA | 8655287 | 42% | 67% | 683 | Search MANTLE+CELL+LYMPHOMA | Search MANTLE+CELL+LYMPHOMA |
2 | T1114 | 578642 | 3% | 72% | 43 | Search T1114 | Search T1114 |
3 | SOX11 | 385921 | 2% | 53% | 39 | Search SOX11 | Search SOX11 |
4 | BCL 1 | 324974 | 2% | 58% | 30 | Search BCL+1 | Search BCL+1 |
5 | MULTIPLE LYMPHOMATOUS POLYPOSIS | 208994 | 1% | 70% | 16 | Search MULTIPLE+LYMPHOMATOUS+POLYPOSIS | Search MULTIPLE+LYMPHOMATOUS+POLYPOSIS |
6 | MANTLE CELL | 193661 | 1% | 54% | 19 | Search MANTLE+CELL | Search MANTLE+CELL |
7 | BLASTOID VARIANT | 189340 | 1% | 92% | 11 | Search BLASTOID+VARIANT | Search BLASTOID+VARIANT |
8 | CENTROCYTIC LYMPHOMA | 186667 | 1% | 76% | 13 | Search CENTROCYTIC+LYMPHOMA | Search CENTROCYTIC+LYMPHOMA |
9 | T1114Q13Q32 | 176030 | 1% | 63% | 15 | Search T1114Q13Q32 | Search T1114Q13Q32 |
10 | CYCLIN D1 | 145306 | 8% | 6% | 136 | Search CYCLIN+D1 | Search CYCLIN+D1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CORTELAZZO, S , PONZONI, M , FERRERI, AJM , DREYLING, M , (2012) MANTLE CELL LYMPHOMA.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 82. ISSUE 1. P. 78 -101 | 156 | 72% | 25 |
2 | CHEAH, CY , SEYMOUR, JF , WANG, ML , (2016) MANTLE CELL LYMPHOMA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 34. ISSUE 11. P. 1256 -1269 | 76 | 69% | 11 |
3 | CABALLERO, D , CAMPO, E , LOPEZ-GUILLERMO, A , MARTIN, A , ARRANZ-SAEZ, R , GINE, E , LOPEZ, A , GONZALEZ-BARCA, E , CANALES, MA , GONZALEZ-DIAZ, M , ET AL (2013) CLINICAL PRACTICE GUIDELINES FOR DIAGNOSIS, TREATMENT, AND FOLLOW-UP OF PATIENTS WITH MANTLE CELL LYMPHOMA. RECOMMENDATIONS FROM THE GEL/TAMO SPANISH COOPERATIVE GROUP.ANNALS OF HEMATOLOGY. VOL. 92. ISSUE 9. P. 1151 -1179 | 120 | 73% | 8 |
4 | SANDER, B , (2011) MANTLE CELL LYMPHOMA: RECENT INSIGHTS INTO PATHOGENESIS, CLINICAL VARIABILITY, AND NEW DIAGNOSTIC MARKERS.SEMINARS IN DIAGNOSTIC PATHOLOGY. VOL. 28. ISSUE 3. P. 245-255 | 106 | 85% | 12 |
5 | CAMPO, E , RULE, S , (2015) MANTLE CELL LYMPHOMA: EVOLVING MANAGEMENT STRATEGIES.BLOOD. VOL. 125. ISSUE 1. P. 48 -55 | 65 | 90% | 29 |
6 | ZELENETZ, AD , GORDON, LI , WIERDA, WG , ABRAMSON, JS , ADVANI, RH , ANDREADIS, CB , BARTLETT, N , BYRD, JC , CZUCZMAN, MS , FAYAD, LE , ET AL (2014) NON-HODGKIN'S LYMPHOMAS, VERSION 4.2014.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 12. ISSUE 9. P. 1282 -1303 | 72 | 87% | 38 |
7 | DREYLING, M , FERRERO, S , HERMINE, O , (2014) HOW TO MANAGE MANTLE CELL LYMPHOMA.LEUKEMIA. VOL. 28. ISSUE 11. P. 2117 -2130 | 89 | 83% | 11 |
8 | SHRESTHA, R , BHATT, VR , MURTHY, GSG , ARMITAGE, JO , (2015) CLINICOPATHOLOGIC FEATURES AND MANAGEMENT OF BLASTOID VARIANT OF MANTLE CELL LYMPHOMA.LEUKEMIA & LYMPHOMA. VOL. 56. ISSUE 10. P. 2759 -2767 | 76 | 95% | 2 |
9 | CHEN, YM , WANG, M , ROMAGUERA, J , (2014) CURRENT REGIMENS AND NOVEL AGENTS FOR MANTLE CELL LYMPHOMA.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 167. ISSUE 1. P. 3 -18 | 78 | 81% | 8 |
10 | DREYLING, M , FERRERO, S , (2016) THE ROLE OF TARGETED TREATMENT IN MANTLE CELL LYMPHOMA: IS TRANSPLANT DEAD OR ALIVE?.HAEMATOLOGICA. VOL. 101. ISSUE 2. P. 104 -114 | 73 | 89% | 0 |
Classes with closest relation at Level 1 |